Cargando…

Clinical characteristics of sarcopenia in patients with alcoholic liver cirrhosis

BACKGROUND AND AIM: Sarcopenia frequently develops in patient with liver cirrhosis (LC). Ethanol reduces muscle protein synthesis and accelerates proteolysis. However, the relationship between heavy alcohol consumption and sarcopenia remains controversial. This study aimed to investigate the charact...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saeki, Chisato, Kanai, Tomoya, Nakano, Masanori, Oikawa, Tsunekazu, Torisu, Yuichi, Saruta, Masayuki, Tsubota, Akihito
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Publishing Asia Pty Ltd 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264247/ https://www.ncbi.nlm.nih.gov/pubmed/34263070 http://dx.doi.org/10.1002/jgh3.12582

Ejemplares similares

Low Serum Branched-chain Amino Acid and Insulin-Like Growth Factor-1 Levels Are Associated with Sarcopenia and Slow Gait Speed in Patients with Liver Cirrhosis
por: Saeki, Chisato, et al.
Publicado: (2020)

Prognostic significance of sarcopenia and severe vitamin D deficiency in patients with cirrhosis
por: Saeki, Chisato, et al.
Publicado: (2023)

The Geriatric Nutritional Risk Index predicts sarcopenia in patients with cirrhosis
por: Saeki, Chisato, et al.
Publicado: (2023)

Low Serum 25-Hydroxyvitamin D Levels Are Related to Frailty and Sarcopenia in Patients with Chronic Liver Disease
por: Saeki, Chisato, et al.
Publicado: (2020)

Clinical Usefulness of FRAX Score for Predicting Sarcopenia in Patients with Chronic Liver Disease
por: Saeki, Chisato, et al.
Publicado: (2021)

Osteosarcopenia predicts poor survival in patients with cirrhosis: a retrospective study
por: Saeki, Chisato, et al.
Publicado: (2023)

Insulin-like growth factor 1 predicts decompensation and long-term prognosis in patients with compensated cirrhosis
por: Saeki, Chisato, et al.
Publicado: (2023)

Comparative assessment of sarcopenia using the JSH, AWGS, and EWGSOP2 criteria and the relationship between sarcopenia, osteoporosis, and osteosarcopenia in patients with liver cirrhosis
por: Saeki, Chisato, et al.
Publicado: (2019)

Relationship between osteoporosis, sarcopenia, vertebral fracture, and osteosarcopenia in patients with primary biliary cholangitis
por: Saeki, Chisato, et al.
Publicado: (2020)

Relationship between Osteosarcopenia and Frailty in Patients with Chronic Liver Disease
por: Saeki, Chisato, et al.
Publicado: (2020)

Plasma pentosidine levels are associated with prevalent fractures in patients with chronic liver disease
por: Saeki, Chisato, et al.
Publicado: (2021)

Effects of denosumab treatment in chronic liver disease patients with osteoporosis
por: Saeki, Chisato, et al.
Publicado: (2020)

Low geriatric nutritional risk index predicts poor prognosis in patients with cirrhosis: a retrospective study
por: Kamioka, Hiroshi, et al.
Publicado: (2023)

Serum Insulin-Like Growth Factor 1 Levels, Facture Risk Assessment Tool Scores and Bone Disorders in Patients with Primary Biliary Cholangitis
por: Saeki, Chisato, et al.
Publicado: (2022)

Safety and efficacy of pentazocine–midazolam combination for pain and anxiety relief in radiofrequency ablation therapy for hepatocellular carcinoma
por: Nakano, Masanori, et al.
Publicado: (2022)

Recent Insights Into the Multiple Pathways Driving Non-alcoholic Steatohepatitis-Derived Hepatocellular Carcinoma
por: Takakura, Kazuki, et al.
Publicado: (2019)

Mouse models for investigating the underlying mechanisms of nonalcoholic steatohepatitis-derived hepatocellular carcinoma
por: Takakura, Kazuki, et al.
Publicado: (2018)

Plasma pentosidine as a useful biomarker of sarcopenia, low gait speed, and mortality in patients with cirrhosis
por: Saeki, Chisato, et al.
Publicado: (2023)

Influencing Factors and Molecular Pathogenesis of Sarcopenia and Osteosarcopenia in Chronic Liver Disease
por: Saeki, Chisato, et al.
Publicado: (2021)

Clinical usefulness of ursodeoxycholic acid for Japanese patients with autoimmune hepatitis
por: Torisu, Yuichi, et al.
Publicado: (2017)

Potential significance of uncovered self‐expandable metal stents for distal malignant biliary obstruction: A propensity score‐adjusted competing risk regression analysis
por: Torisu, Yuichi, et al.
Publicado: (2022)

Identification of circulating microRNAs as potential biomarkers for hepatic necroinflammation in patients with autoimmune hepatitis
por: Saeki, Chisato, et al.
Publicado: (2022)

Pancreatic cancer screening in patients with presumed branch-duct intraductal papillary mucinous neoplasms
por: Torisu, Yuichi, et al.
Publicado: (2019)

Characterisation of blood microbiota in patients with liver cirrhosis
por: Kajihara, Mikio, et al.
Publicado: (2019)

Hemobilia Derived from Cystic Artery Pseudoaneurysm
por: Tanaka, Takayuki, et al.
Publicado: (2019)

Histological and biochemical evaluation of transforming growth factor-β activation and its clinical significance in patients with chronic liver disease
por: Yokoyama, Hiroshi, et al.
Publicado: (2019)

Centrilobular zonal necrosis is a unique subtype of autoimmune hepatitis: A cohort study
por: Ueda, Kaoru, et al.
Publicado: (2022)

Sarcopenia and Frailty in Liver Cirrhosis
por: Nishikawa, Hiroki, et al.
Publicado: (2021)

Dyrk2 gene transfer suppresses hepatocarcinogenesis by promoting the degradation of Myc and Hras
por: Kamioka, Hiroshi, et al.
Publicado: (2023)

The association between sarcopenia and endotoxin in patients with alcoholic cirrhosis
por: Sato, Shinya, et al.
Publicado: (2021)

Chronic intestinal pseudo-obstruction with pneumatosis cystoides intestinalis in a patient with systemic sclerosis: A case report
por: Mitsuyoshi, Yuki, et al.
Publicado: (2019)

Liver Cirrhosis and Sarcopenia from the Viewpoint of Dysbiosis
por: Nishikawa, Hiroki, et al.
Publicado: (2020)

Sarcopenia as a prognostic indicator of liver cirrhosis
por: Kim, Sung‐Eun, et al.
Publicado: (2021)

Liver cirrhosis and sarcopenia: a dreadful combination
por: Kuchay, Mohammad Shafi, et al.
Publicado: (2022)

Mechanisms of sarcopenia in liver cirrhosis and the role of myokines
por: Geladari, Eleni, et al.
Publicado: (2023)

Treatment on the Spleen Prevents the Progression of Secondary Sarcopenia in Patients With Liver Cirrhosis
por: Hirooka, Masashi, et al.
Publicado: (2020)

The Clinical Potential of Oligonucleotide Therapeutics against Pancreatic Cancer
por: Takakura, Kazuki, et al.
Publicado: (2019)

Impact of Sarcopenia on Survival and Clinical Outcomes in Patients With Liver Cirrhosis
por: Topan, Mirabela-Madalina, et al.
Publicado: (2021)

Impact of qualitative endoscopic ultrasonography on fatty pancreas at a referral medical center
por: Kawamura, Atsushi, et al.
Publicado: (2021)

Sarcopenia in liver cirrhosis: perspectives from epigenetics and microbiota
por: Xu, Jia-qi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_heh8c58a6qhri4o43pd89j0ph3